Home LiteratureArticle Details
PMID: 12402152 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Elevated c-Src is linked to altered cell-matrix adhesion rather than proliferation in KM12C human colorectal cancer cells.

British journal of cancer ·Vol. 87 ·No. 10 ·2002-11-04 ·Pages 1128-35

Jones RJ, Avizienyte E, Wyke AW, Owens DW, Brunton VG, Frame MC

Abstract

Elevated expression and/or activity of c-Src, the prototype of the Src family of protein tyrosine kinases, is associated with the development of human colon cancer. However, despite the known pleiotropic effects of these kinases in promoting (a) cell growth downstream of growth factor receptors, and (b) the dynamic regulation of integrin adhesions in fibroblast model systems, their precise role in epithelial cancer cells is unknown. Here we addressed whether elevated expression and activity of cellular Src alters cell proliferation and/or cell-matrix adhesion in cancer cells from the Fidler model of colorectal metastasis. Although elevated Src correlates with ability to metastasise to the liver after intrasplenic injection, we found that this was not linked to enhanced growth, either in vitro or in vivo as sub-cutaneous tumours. However, elevated Src was associated with enhanced attachment to extracellular matrix. In addition, adhesion to fibronectin, was suppressed by agents that inhibited Src activity, while enforced elevation of Src in non-metastatic cells was sufficient to stimulate adhesion to fibronectin and enhanced assembly of adhesion complexes, without influencing cell growth. Thus, we conclude that one role of elevated Src in human colon cancer cells is to modulate integrin-dependent cell-matrix attachment and formation of adhesion structures, which may, in turn, influence cell motility and integrin-dependent cellular responses.

MeSH Terms
Cell Adhesion Cell-Matrix Junctions/physiology Colorectal Neoplasms/metabolism,pathology Humans Neoplasm Metastasis Oncogene Protein pp60(v-src)/antagonists & inhibitors,metabolism Protein-Tyrosine Kinases/antagonists & inhibitors,physiology Tumor Cells, Cultured
Chemicals
Protein-Tyrosine Kinases Oncogene Protein pp60(v-src)
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Jones R J
Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, Scotland, UK.
Avizienyte E
Wyke A W
Owens D W
Brunton V G
Frame M C
References (36)
36 references, click to expand
  1. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
    Cell Growth Differ. 1997 Mar;8(3):269-74 PMID: 9056668
  2. Absence of genetic alteration at codon 531 of the human c-src gene in 479 advanced colorectal cancers from Japanese and Caucasian patients.
    Cancer Res. 1999 Sep 1;59(17):4222-4 PMID: 10485460
  3. The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility.
    EMBO J. 1998 Jan 2;17(1):81-92 PMID: 9427743
  4. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential.
    Oncogene. 1997 Dec 18;15(25):3083-90 PMID: 9444956
  5. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence.
    Oncogene. 1998 Apr 16;16(15):2017-28 PMID: 9591786
  6. Activating SRC mutation in a subset of advanced human colon cancers.
    Nat Genet. 1999 Feb;21(2):187-90 PMID: 9988270
  7. Src family kinases are required for integrin but not PDGFR signal transduction.
    EMBO J. 1999 May 4;18(9):2459-71 PMID: 10228160
  8. Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest.
    Cancer Res. 1999 Dec 15;59(24):6145-52 PMID: 10626805
  9. Src family tyrosine kinases and growth factor signaling.
    Exp Cell Res. 2000 Jan 10;254(1):1-13 PMID: 10623460
  10. No evidence of correlation between mutation at codon 531 of src and the risk of colon cancer in Chinese.
    Cancer Lett. 2000 Mar 31;150(2):201-4 PMID: 10704743
  11. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
    Oncogene. 2000 Apr 20;19(17):2075-85 PMID: 10815799
  12. The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via phosphatidylinositol 3-kinase.
    Mol Cell Biol. 2000 Sep;20(17):6518-36 PMID: 10938128
  13. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.
    Mol Cell Biol. 2000 Dec;20(23):9018-27 PMID: 11074000
  14. Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients.
    Br J Cancer. 2001 Jan;84(2):196-8 PMID: 11161376
  15. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.
    Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7319-24 PMID: 11404481
  16. Src kinase contributes to the metastatic spread of carcinoma cells.
    Oncogene. 2002 Apr 4;21(15):2347-56 PMID: 11948418
  17. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling.
    Nat Cell Biol. 2002 Aug;4(8):632-8 PMID: 12134161
  18. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.
    Cancer Res. 1988 Apr 1;48(7):1943-8 PMID: 3349467
  19. Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells.
    Oncogene Res. 1987 Jul;1(2):149-68 PMID: 2453014
  20. pp60c-src activation in human colon carcinoma.
    J Clin Invest. 1989 Jun;83(6):2025-33 PMID: 2498394
  21. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.
    Proc Natl Acad Sci U S A. 1990 Jan;87(2):558-62 PMID: 2105487
  22. Mitogenesis induced by pp60v-src is not accompanied by increased expression of immediate early response genes.
    Oncogene. 1990 Feb;5(2):161-9 PMID: 2108404
  23. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.
    J Clin Invest. 1993 Jan;91(1):53-60 PMID: 7678609
  24. Site-specific differences in pp60c-src activity in human colorectal metastases.
    J Surg Res. 1993 Apr;54(4):293-8 PMID: 7687314
  25. Src family tyrosine kinases and the response to platelet-derived growth factor.
    Adv Second Messenger Phosphoprotein Res. 1993;28:187-94 PMID: 8398402
  26. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.
    J Clin Invest. 1994 Feb;93(2):509-15 PMID: 7509341
  27. Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells.
    Mol Cell Biol. 1995 May;15(5):2374-82 PMID: 7739521
  28. c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism.
    Genes Dev. 1995 Jun 15;9(12):1505-17 PMID: 7541382
  29. Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division.
    Science. 1995 Sep 15;269(5230):1567-9 PMID: 7545311
  30. pp60c-src is a positive regulator of growth factor-induced cell scattering in a rat bladder carcinoma cell line.
    J Cell Biol. 1995 Nov;131(3):761-73 PMID: 7593195
  31. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src.
    Nature. 1995 Nov 30;378(6556):509-12 PMID: 7477410
  32. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling.
    J Biol Chem. 1996 Jul 12;271(28):16798-806 PMID: 8663329
  33. Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion.
    Br J Cancer. 1997;75(2):241-50 PMID: 9010033
  34. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
    Oncogene. 1997 Jan 23;14(3):283-93 PMID: 9018114
  35. Phosphorylation of p125FAK and paxillin focal adhesion proteins in src-transformed cells with different metastatic capacity.
    FEBS Lett. 1999 Jul 16;455(1-2):145-8 PMID: 10428489
  36. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice.
    Genes Dev. 1997 Nov 1;11(21):2835-44 PMID: 9353253
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
2002-11-04
Pages
1128-35
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2376185
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]